The Nobel Prize for Peripheral Immune Tolerance: What It Might Mean for Neurodiversity and Childhood Cancer

A Nobel Moment for the Immune System

The 2025 Nobel Prize in Physiology or Medicine went to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their discoveries concerning peripheral immune tolerance — how the immune system restrains itself from attacking the body’s own tissues. Their work put a bright spotlight on regulatory T cells (Tregs) and the FOXP3 gene, the master regulator of Treg identity.

First, to ground what was just awarded:

The 2025 Nobel Prize in Physiology or Medicine went to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for discovering mechanisms of peripheral immune tolerance — i.e. how the immune system keeps itself in check outside of the central (thymic / bone marrow) tolerance checkpoints. (Nature)
A central factor in that discovery is the role of regulatory T cells (Tregs), especially CD4⁺ FOXP3⁺ Tregs, in suppressing autoreactive T cells in peripheral tissues, producing anti-inflammatory cytokines (e.g. IL-10, TGF-β), consuming IL-2, expressing CTLA-4 to diminish T cell costimulation, and so on. (Cell)
Brunkow and Ramsdell’s work is directly tied to FOXP3 (on the X chromosome), including how mutations in FOXP3 lead to severe autoimmune syndromes (e.g. IPEX syndrome) in humans (and scurfy in mice). (The Guardian)
The discovery opens up new vistas: If one can manipulate peripheral tolerance — e.g. expand or stabilize Tregs, or modulate tolerogenic dendritic cells (tol-DCs) — one can envision therapies for autoimmunity, transplantation, cancer immunotherapy (by tipping the balance between tolerance vs. immune activation) and possibly other immune-mediated disorders. (Frontiers)

So in effect, the Nobel recognition is in part for revealing a “governance layer” in immunology — how the immune system restrains itself once cells are in the periphery.

From the Thymus to the Brain: The Overlooked Connection

The thymus is where T cells mature. As highlighted by WEHI, the thymus shrinks after puberty (thymic involution), reducing our ability to generate new T cells later in life. That matters for infection, cancer surveillance, and immune balance. But an equally interesting question is what happens earlier, during pregnancy and early childhood, when the immune and nervous systems are co-developing.

Immune signals shape neurodevelopmental processes such as microglial activity, synaptic pruning, and neural plasticity. A subtle skew in immune tolerance could, in principle, tilt brain wiring toward different developmental trajectories — including profiles we describe today as autism, ADHD, or dyslexia.

Key gaps include:

Causality vs downstream effects
Is altered immune signaling (or defective peripheral tolerance) a cause, a modulator, or a consequence of neurodevelopmental trajectories? It is notoriously difficult to separate systemic immune changes (which may reflect stress, comorbidities, or secondary phenomena) from primary etiologic mechanisms.
Temporal specificity
If immune dysregulation matters, when is it relevant? Prenatal? Perinatal? Early childhood? Adolescence? Distinguishing windows of vulnerability is key.
Cell type specificity and compartments
The immune system is hugely heterogeneous. Which immune cell subsets (e.g. Tregs, microglia, astrocytes, perivascular macrophages) matter most in the brain? Do peripheral Tregs communicate or influence central (brain) tolerance or immunoregulation? The blood–brain barrier and “immune privilege” add complexity.
Sex / X-linked / Female protective effect
The X chromosome and female protective effects — a very relevant angle given that FOXP3, the Treg master regulator, is on the X chromosome. Mutations or regulatory variation (including epigenetic regulation, X-inactivation, skewing, escape from inactivation) in X-linked immune-regulatory genes could in principle yield sex-biased vulnerability. But this is a niche area and not yet well explored in the context of neurodevelopment.
Intersection with cancer / autoimmune risk
If peripheral tolerance is defective, one might expect increased autoimmune phenomena — which is indeed observed in some individuals with neurodevelopmental disorders (or in family history). But connections to cancer (e.g. Hodgkin lymphoma, as you mentioned) are less documented, though immune surveillance is a major player in cancer biology. Whether particular immunoregulatory variants contribute simultaneously to neurodivergence risk and cancer/autoimmunity vulnerability is a very intriguing possibility but largely speculative so far.

Linking Treg / peripheral tolerance with neurodiversity, especially in the context of X-chromosome modulation?

Some thoughts on Potential Mechanistic Hypotheses / Models:

X-linked variation in Treg regulatory genes
Since FOXP3 is X-linked, variation in its regulatory control (e.g. promoter/enhancer variants, epigenetic marks, X-inactivation skewing) might influence Treg function (quantity, stability, suppressive capacity). In a neurodevelopmental context, modest dysregulation might tip the balance subtly (not full-blown autoimmunity, but a shifted homeostatic baseline).
This could help explain why females may need a higher mutational/variant burden to manifest neurodivergent traits (i.e. a protective buffer).
Treg–microglia / Treg–brain immune crosstalk
A hypothesis: peripheral Tregs (or induced Tregs migrating into CNS border areas) modulate neuroimmune homeostasis (via cytokines, trophic factors, immune suppression) during development. If Treg function is suboptimal, microglial activation or glial priming may be higher, leading to altered synaptic pruning or inflammation-driven developmental trajectories.
Maternal–foetal immune interactions
During pregnancy, maternal-fetal immune tolerance is critical. Variation in maternal Treg function or maternal peripheral tolerance might impact the in utero environment, influencing neuroimmune priming of the developing fetal brain. (There is already literature on maternal immune activation (MIA) in autism models.) Wiley Online Library+1
Epigenetic programming via inflammatory insults / dysregulated tolerance
A child (or fetus) exposed to mild immune dysregulation or inflammatory challenges might have epigenetic remodeling in neuroimmune regulatory genes. If a child inherits borderline Treg competence (via variant alleles) and experiences an inflammatory “push,” it might push toward divergent developmental courses.
Trade-offs: immune tolerance vs immune surveillance
There is a tension in the immune system: more tolerance implies less aggressive surveillance (e.g. of tumor or infected cells); less tolerance implies more autoimmunity risk. Perhaps some allelic configurations confer a slightly “looser” tolerance baseline that primes for heightened immunity / reactivity, which in turn might have (in some developmental windows) effects on neurodevelopment.

When Immune Tolerance Fails — or Overcompensates

Peripheral immune tolerance is a tightrope act:

Too little tolerance, and we get autoimmunity or inflammation.
Too much, and tumors or chronic infections can slip past immune surveillance.

Perhaps neurodiversity fits somewhere along this same spectrum. A slight skew in immune signaling during early development could tilt neural patterning toward heightened sensitivity, divergent connectivity, or faster associative learning — the hallmarks of the AuDHD brain.

This could help explain why some families (like mine) show patterns of both immune-related conditions (asthma, allergies, thyroiditis, Hodgkin’s lymphoma) and neurotypes (autism, ADHD, dyslexia). The link might not be linear — more like a multidimensional web where genes, epigenetics, and environmental stressors interact across generations. Neurodiversity, in that sense, is not a defect of regulation but a variation of balance — perhaps even a natural counterpart to the immune system’s many ways of learning tolerance.

IDB: Interest Driven Brain

Search This Blog